As per Data Bridge Market Research Analysis the global neurovascular embolization devices market size was valued at USD 2.38 billion in 2025 and is expected to reach USD 3.55 billion by 2033, at a CAGR of 5.16% during the forecast period
The market growth is largely fueled by the increasing prevalence of intracranial aneurysms, arteriovenous malformations (AVMs), and other neurovascular disorders, along with a strong global shift toward minimally invasive neuro‑interventional procedures, which are safer and more effective than traditional surgical approaches
Furthermore, technological advancements in embolic coils, flow diversion devices, liquid embolic agents, and aneurysm clips, coupled with rising demand for effective and targeted treatment options in hospitals, specialty clinics, and outpatient settings, are positioning neurovascular embolization solutions as essential components of modern cerebrovascular therapy. These converging factors are accelerating adoption and significantly driving the industry’s growth